Choledochoduodenostomy. A safe and efficacious alternative in the treatment of biliary tract disease.
A review of 75 patients who underwent side-to-side choledochoduodenostomy as primary or secondary treatment for various forms of biliary tract disease was performed. Ages of patients ranged from 23 to 89 years (mean of 61 years), with 40 per cent of patients 70 years or older. All anastomoses were created with a minimal diameter of 2 cm. During a follow-up period ranging from 6 months to 8 years, there was no incidence of ascending cholangitis or anastomotic stricture. Six patients continued to have non-specific complaints of abdominal pain postoperatively that could not be attributed to the "sump syndrome" after necessary diagnostic studies were performed. The overall morbidity and mortality was 6.6 per cent and 1.3 per cent, respectively. This study confirms the notion that choledochoduodenostomy can be performed safely, with good results, particularly in the expanding high-risk elderly patient population.